praxismedicines.com (PRAX) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Geopolitik beqarorlik neyroterapiya uchun komponentlar logistikasini buzmoqda, sanktsiyalar esa bir nechta hududlarda test sinovlarini cheklamoqda. GURU.Markets platformasidagi Praxis Precision Medicines (PRAX) uchun ushbu narx harakati 0.00 ko'rsatkichini aks ettirdi. Praxis Precision Medicines (PRAX) muvaffaqiyatsizlik xavfini minimallashtirish uchun ruhiy buzilishlar dori vositalarining diversifikatsiyalashgan portfeliga tayanadi, patent himoyasi va qat'iy FDA talablari esa ushbu sohadagi innovatsiyalarining eksklyuzivligini ta'minlaydi.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_PRAX_-_Praxis-Precision-Medicines_-_Long-Term-Debt-to-Equity-Ratio "PRAX - Praxis Precision Medicines, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Praxis Precision Medicines kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Praxis Precision Medicines|PRAX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati praxismedicines.com|PRAX - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Praxis Precision Medicines, Inc.|PRAX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Praxis Precision Medicines|Shoshilinch likvidlik koeffitsiyenti praxismedicines.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:Praxis Precision Medicines Inc - PRAX
Praxis Precision Medicines (PRAX) uchun qarz kapitalini jalb qilish va klinik sinovlarning muvaffaqiyatsizligi risklarini muvozanatga keltirish juda muhimdir. Uzoq muddatli kreditlarning kapitalga nisbatan ulushini tahlil qilish, bir yildan ortiq muddatga ega majburiyatlarning sof aktivlarga nisbatini o'lchash orqali moliyaviy leveraj darajasini baholash imkonini beradi, bu esa uzoq davom etadigan ishlanmalar davrida kompaniyaning likvidlik tanqisligiga chidamliligini belgilaydi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|harmonybiosciences.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX (Amylyx Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzning kapitalga nisbati Anavex Life Sciences Corp AVXL|CBLL: Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA (Prothena Corporation PLC) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ALEC: Uzoq muddatli qarzning kapitalga nisbati|ANNX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp|Neurogene Therapeutics (NGNE) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics, Inc. NMRA|SCLX (Scilex Holding) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|TVGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACOG (Alpha Cognition)|CGTX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati inhibikase.com (IKT)|SAVA (Cassava Sciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Therapeutics (ASRT)|Uzoq muddatli qarzning kapitalga nisbati COYA|Uzoq muddatli qarzdorlikning kapitalga nisbati vistagen.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics OVID|Uzoq muddatli qarzdorlikning kapitalga nisbati acumenpharm.com (ABOS)|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Alterity Therapeutics ATHE|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati PepGen (PEPG)|Uzoq muddatli qarzning o'z kapitaliga nisbati Jupiter Neurosciences Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi RLMD (relmada.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio)|GRCE (gracetx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuroscience Inc AIFF|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati revivapharma.com|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NRXS|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Passage Bio Corp (PASG) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzning o'z kapitaliga nisbati minervaneurosciences.com NERV|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Addex Therapeutics Ltd. (ADXN)|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Avenue Therapeutics Inc. (ATXI) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Uzoq muddatli qarzning kapitalga koeffitsiyenti ELYM|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|MRNS (Marinus) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NKGN|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SAGE (sagerx.com)|Uzoq muddatli qarzning kapitalga nisbati SNPX|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Anew Medical Inc. WENA|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati